vs
Side-by-side financial comparison of Autolus Therapeutics plc (AUTL) and OP Bancorp (OPBK). Click either name above to swap in a different company.
OP Bancorp is the larger business by last-quarter revenue ($24.3M vs $21.2M, roughly 1.1× Autolus Therapeutics plc). OP Bancorp produced more free cash flow last quarter ($23.4M vs $-72.3M).
Autolus Therapeutics plc is a clinical-stage biopharmaceutical company specializing in the development of next-generation engineered chimeric antigen receptor T-cell (CAR-T) therapies for the treatment of hematological malignancies and solid tumors. It operates in the global oncology biotech market, advancing a pipeline of targeted immunotherapy candidates across multiple clinical development stages.
OP Bancorp is the bank holding company for Open Bank, a community-oriented commercial bank headquartered in California, United States. It provides a full range of banking solutions including deposit accounts, commercial real estate loans, small business financing, and consumer lending products, primarily catering to small and medium-sized enterprises, local immigrant communities, and retail clients across Southern California.
AUTL vs OPBK — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $21.2M | $24.3M |
| Net Profit | $-79.1M | — |
| Gross Margin | — | — |
| Operating Margin | -337.9% | 39.2% |
| Net Margin | -373.3% | — |
| Revenue YoY | — | 13.7% |
| Net Profit YoY | 3.6% | — |
| EPS (diluted) | $-0.30 | $0.48 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $24.3M | ||
| Q3 25 | $21.2M | $24.5M | ||
| Q2 25 | $20.9M | $23.7M | ||
| Q1 25 | $9.0M | $22.2M | ||
| Q4 24 | — | $21.3M | ||
| Q3 24 | $0 | $20.7M | ||
| Q2 24 | $0 | $20.4M | ||
| Q1 24 | $10.1M | $19.6M |
| Q4 25 | — | — | ||
| Q3 25 | $-79.1M | $6.7M | ||
| Q2 25 | $-47.9M | $6.3M | ||
| Q1 25 | $-70.2M | $5.6M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-82.1M | $5.4M | ||
| Q2 24 | $-58.3M | $5.4M | ||
| Q1 24 | $-52.7M | $5.2M |
| Q4 25 | — | 39.2% | ||
| Q3 25 | -337.9% | 39.5% | ||
| Q2 25 | -292.6% | 35.7% | ||
| Q1 25 | -726.3% | 34.6% | ||
| Q4 24 | — | 31.2% | ||
| Q3 24 | — | 36.5% | ||
| Q2 24 | — | 37.2% | ||
| Q1 24 | -384.1% | 37.1% |
| Q4 25 | — | — | ||
| Q3 25 | -373.3% | 27.4% | ||
| Q2 25 | -229.0% | 26.7% | ||
| Q1 25 | -781.1% | 25.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 26.2% | ||
| Q2 24 | — | 26.7% | ||
| Q1 24 | -522.1% | 26.7% |
| Q4 25 | — | $0.48 | ||
| Q3 25 | $-0.30 | $0.45 | ||
| Q2 25 | $-0.18 | $0.42 | ||
| Q1 25 | $-0.26 | $0.37 | ||
| Q4 24 | — | $0.33 | ||
| Q3 24 | $-0.31 | $0.36 | ||
| Q2 24 | $-0.22 | $0.36 | ||
| Q1 24 | $-0.24 | $0.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $86.1M | $167.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $265.5M | $227.9M |
| Total Assets | $661.9M | $2.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $167.3M | ||
| Q3 25 | $86.1M | $166.7M | ||
| Q2 25 | $123.8M | $205.4M | ||
| Q1 25 | $95.8M | $198.9M | ||
| Q4 24 | — | $134.9M | ||
| Q3 24 | $657.1M | $166.8M | ||
| Q2 24 | $705.9M | $127.7M | ||
| Q1 24 | $758.5M | $139.2M |
| Q4 25 | — | $227.9M | ||
| Q3 25 | $265.5M | $221.5M | ||
| Q2 25 | $346.5M | $213.7M | ||
| Q1 25 | $371.1M | $210.1M | ||
| Q4 24 | — | $205.0M | ||
| Q3 24 | $477.0M | $203.6M | ||
| Q2 24 | $527.8M | $195.9M | ||
| Q1 24 | $582.0M | $194.7M |
| Q4 25 | — | $2.7B | ||
| Q3 25 | $661.9M | $2.6B | ||
| Q2 25 | $721.0M | $2.6B | ||
| Q1 25 | $746.3M | $2.5B | ||
| Q4 24 | — | $2.4B | ||
| Q3 24 | $827.5M | $2.4B | ||
| Q2 24 | $853.6M | $2.3B | ||
| Q1 24 | $901.4M | $2.2B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-67.9M | $26.2M |
| Free Cash FlowOCF − Capex | $-72.3M | $23.4M |
| FCF MarginFCF / Revenue | -341.2% | 96.2% |
| Capex IntensityCapex / Revenue | 20.8% | 11.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-322.5M | $43.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $26.2M | ||
| Q3 25 | $-67.9M | $23.9M | ||
| Q2 25 | $-72.8M | $-7.0M | ||
| Q1 25 | $-75.6M | $5.6M | ||
| Q4 24 | — | $31.2M | ||
| Q3 24 | $-76.7M | $13.3M | ||
| Q2 24 | $-51.1M | $15.8M | ||
| Q1 24 | $-40.5M | $-3.2M |
| Q4 25 | — | $23.4M | ||
| Q3 25 | $-72.3M | $23.4M | ||
| Q2 25 | $-80.1M | $-7.7M | ||
| Q1 25 | $-83.8M | $4.2M | ||
| Q4 24 | — | $29.7M | ||
| Q3 24 | $-86.3M | $12.8M | ||
| Q2 24 | $-51.9M | $15.7M | ||
| Q1 24 | $-41.0M | $-3.2M |
| Q4 25 | — | 96.2% | ||
| Q3 25 | -341.2% | 95.6% | ||
| Q2 25 | -382.6% | -32.5% | ||
| Q1 25 | -933.1% | 19.0% | ||
| Q4 24 | — | 139.0% | ||
| Q3 24 | — | 61.5% | ||
| Q2 24 | — | 77.0% | ||
| Q1 24 | -406.8% | -16.6% |
| Q4 25 | — | 11.5% | ||
| Q3 25 | 20.8% | 2.3% | ||
| Q2 25 | 34.8% | 3.0% | ||
| Q1 25 | 91.8% | 6.4% | ||
| Q4 24 | — | 7.3% | ||
| Q3 24 | — | 2.8% | ||
| Q2 24 | — | 0.4% | ||
| Q1 24 | 5.3% | 0.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | 3.57× | ||
| Q2 25 | — | -1.10× | ||
| Q1 25 | — | 1.02× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.45× | ||
| Q2 24 | — | 2.90× | ||
| Q1 24 | — | -0.60× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
